Healthscope Ltd. received an unsolicited acquisition offer from Toronto-listed Brookfield Asset Management Inc. at A$2.50 per share.
The offer values the Australian hospital operator at A$4.35 billion, or $3.3 billion, which is about $180 million more than what a private equity firm offered it in April, according to a Reuters report.
The latest bid represents a premium of about 23% to Healthscope's closing share price of A$2.03 on April 24 — the last trading day before the company received a A$2.36 per share bid from Australian private equity firm BGH Capital and its partners, Healthscope said in a press release.
Brookfield intends to allow existing Healthscope shareholders an opportunity to invest alongside Brookfield in a privatized Healthscope, which may result in them owning a "significant minority position" in the company, Healthscope added.
Brookfield's proposal is subject to a number of conditions, including due diligence; arranging debt financing for the acquisition; and the satisfaction of a "level playing field condition."
The Healthscope board is assessing the two proposals it has received and shareholders do not need to take any action as of now, the Australian company added.